Detailed price information for Amn Healthcare Services Inc (AMN-N) from The Globe and Mail including charting and trades.

Detailed price information for Avadel Pharmaceuticals Plc ADR (AVDL-Q) from The Globe and Mail including charting and trades.

Bell Potter notes that Neuren has released an update on Acadia's sales and its expected royalties. It said: ...

Second Quarter 2025 Results Key Financial Results Revenue: US$264.6m (up ...

Biotech group Neuren Pharmaceuticals has reported a 14% uptick in quarterly US sales of its Retts syndrome treatment Daybue.

Shares little changed from Wednesday’s record; ASX hammered on monopoly chatter, costs hit; Domain to exit sharemarket after ...

Shares little changed from Wednesday’s record; ASX hammered on monopoly chatter, costs hit; Domain to exit sharemarket after ...

Despite firming US sales of its Rett syndrome treatment Daybue, Neuren Pharmaceuticals (ASX:NEU) says two-thirds of eligible ...

Acadia Pharma (ACAD) is scheduled to announce Q2 earnings results on Wednesday, August 6th, after market close.

Acadia Pharmaceuticals Inc. ACAD) on Wednesday reported second-quarter net income of $26.7 million. The San Diego-based ...

Aug 2025 - Acadia Pharmaceuticals reports a 14% increase in DAYBUE™ net sales, boosting Neuren's royalty income.

Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that it will participate in a fireside chat at Canaccord Genuity 45th Annual Growth Conference on Wednesday, August 13, 2025 at 2:30 p.m.